SEQSTER, a healthcare data platform, has partnered with Antidote Technologies, a digital patient engagement company, to improve clinical trial enrollment and timelines.
Through the partnership, Antidote will leverage SEQSTER's data platform to match patients to clinical trials based on their genomic data, lifestyle factors, and medical history. This partnership aims to enhance Antidote's precision recruitment process, identify suitable participants more effectively, and reduce the time required to bring new treatments to market.
Based in California, SEQSTER is a healthcare technology company that focuses on providing real-time access to comprehensive health data, enabling the aggregation of disparate health data sources. Its enterprise operating system integrates electronic health records (EHRs), genomic data (DNA), wearable devices, pharmacy data, and social determinants of health (SDoH). SEQSTER’s platform creates longitudinal health records that facilitate efficient patient care, clinical research, and health data management.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.